Medical Condition News

RSS

Glenmark's GBR 500 enters Phase II clinical development for severe ulcerative colitis

Glenmark Pharmaceuticals S.A. (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited (GPL), announced today that GBR 500 has entered Phase II clinical development.

13 Sep 2012

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

The U.S. Food and Drug Administration today approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

ATA, AACE develop new guidelines for diagnosis and treatment of hypothyroidism

New evidence-based guidelines have been released for the diagnosis and treatment of hypothyroidism, a complex disease caused by an underactive thyroid gland that cannot produce enough thyroid hormone.

13 Sep 2012

Daily noise exposure can lead to permanent hearing loss in nightclub bar employees

New research shows that nightclub bar employees could be exposed to noise levels almost four times over the legal limit. Aoife Kelly, a PhD researcher in Dublin Institute of Technology also found that nightclub managers showed little awareness of the relevant health and safety legislation and had not provided hearing tests for their employees or provided training in noise awareness.

13 Sep 2012

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

New research offers ways in which investigators can reduce amount of Cd in foods

A number of environmental toxins pose considerable health threats to humans, and the heavy metal cadmium (Cd) ranks high on the list. Most of us are exposed to it through plant-derived foods such as grains and vegetables. Now, new research offers ways in which investigators can reduce the amount of Cd found in the food we eat, according to a review published online September 12th in the Cell Press journal Trends in Plant Science.

13 Sep 2012

Exercise may affect how people respond to food cues

It is commonly assumed that you can "work up an appetite" with a vigorous workout. Turns out that theory may not be completely accurate - at least immediately following exercise.

13 Sep 2012

Exposure to road traffic noise may increase risk of annoyance or sleep disturbance

The World Health Organization recently recognized environmental noise as harmful pollution, with adverse psychosocial and physiological effects on public health. A new study of noise pollution in Fulton County, Georgia, suggests that many residents are exposed to high noise levels that put them at risk of annoyance or sleep disturbance, which can have serious health consequences.

12 Sep 2012

Data from Oncolytics’ REOLYSIN Phase III combination trial on head and neck cancers

Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).

12 Sep 2012

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.

12 Sep 2012

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).

12 Sep 2012

Ageing in neurons follows same rules as in senescing fibroblasts

The ageing process has its roots deep within the cells and molecules that make up our bodies. Experts have previously identified the molecular pathway that react to cell damage and stems the cell's ability to divide, known as cell senescence.

12 Sep 2012

NCDs must be included in new global development goals

In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."

12 Sep 2012

Annual economic cost of chronic pain is as high as $635 billion: Study

Health economists from Johns Hopkins University writing in The Journal of Pain (www.jpain.org) reported the annual cost of chronic pain is as high as $635 billion a year, which is more than the yearly costs for cancer, heart disease and diabetes.

12 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

Noisy environments cause ears of people with hearing impairments to work differently

The world continues to be a noisy place, and Purdue University researchers have found that all that background chatter causes the ears of those with hearing impairments to work differently.

12 Sep 2012

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

Sucampo Pharmaceuticals, Inc. today announced that it has received approval from the Medicines and Healthcare products Regulatory Agency for AMITIZA (lubiprostone) 24 mcg twice daily for the treatment of chronic idiopathic constipation (CIC) and associated symptoms in adults, when response to diet and other non-pharmacological measures (e.g., educational measures, physical activity) are inappropriate.

12 Sep 2012

U.S. to cover costs of cancer monitoring, treatment for 9/11 first responders

The 70,000 surviving firefighters, police officers and other first responders who raced to the World Trade Center after the attacks of September 11, 2001 will be entitled to free monitoring and treatment for some 50 forms of cancer.

12 Sep 2012

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

University of Minnesota chemist Christy Haynes has been named one of Popular Science magazine's "Brilliant 10," an honor that recognizes an elite group of young scientists whose research is expected to dramatically impact their fields. Haynes' profile was published today on the PopSci website and is featured in the Popular Science magazine now on newsstands.

12 Sep 2012

Daily low-dose inhaled corticosteroids do not benefit asthmatics

For two decades, asthma treatment for millions of people with a milder form of the disease has consisted of daily inhaled steroid medicine to reduce inflammation. Now, a new study has found that asthmatics who take the low-dose medication as a daily routine do no better than those who turn to their inhalers only when they have symptoms.

12 Sep 2012

Medical Condition News

Glenmark's GBR 500 enters Phase II clinical development for severe ulcerative colitis

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

ATA, AACE develop new guidelines for diagnosis and treatment of hypothyroidism

Daily noise exposure can lead to permanent hearing loss in nightclub bar employees

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

New research offers ways in which investigators can reduce amount of Cd in foods

Exercise may affect how people respond to food cues

Exposure to road traffic noise may increase risk of annoyance or sleep disturbance

Data from Oncolytics’ REOLYSIN Phase III combination trial on head and neck cancers

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Ageing in neurons follows same rules as in senescing fibroblasts

NCDs must be included in new global development goals

Annual economic cost of chronic pain is as high as $635 billion: Study

UB researchers receive NFL grant for sports-related medical research on concussion

Noisy environments cause ears of people with hearing impairments to work differently

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

U.S. to cover costs of cancer monitoring, treatment for 9/11 first responders

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

Daily low-dose inhaled corticosteroids do not benefit asthmatics

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News